Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Open accessThe DOI matches its Crossref record; 244 of the 246 references it cites were found in a registry or an index.
Abstract
Background.: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. Methods.: A task force supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America searched, selected, and synthesized relevant evidence. The evidence was then used as the basis for recommendations about the diagnosis of tuberculosis disease and LTBI in adults and children. The recommendations were formulated, written, and graded using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) approach. Results.: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided. Six of the recommendations are strong, whereas the remaining 17 are conditional. Conclusions.: These guidelines are not intended to impose a standard of care. They provide the basis for rational decisions in the diagnosis of tuberculosis in the context of the existing evidence. No guidelines can take into account all of the often compelling unique individual clinical circumstances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, culture may lead to misclassification of some cases of extrapulmonary tuberculosis as ‘not tuberculosis', owing to the paucibacillary nature of the disease.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“This means that culture may have low sensitivity for extrapulmonary tuberculosis overall and further that culture sensitivity may differ for different forms of extrapulmonary tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“A recent evidence synthesis reported sensitivities of 72% to 88% in lymph node tissue, 28% to 81% in pleural fluid, 90% in pleural tissue, and 31% to 56% in CSF. Specificity ranged from 90% to 100% (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“For the 'Summary of findings' tables for CSF and pleural fluid, we provide evidence using culture as the reference standard, which is considered the best reference standard for tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 3×
“These assays are promising, but are not yet commercially available [146, 159, 160].”
BackgroundMethodGrading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732 · cited 1×
“The emergence of drug-resistant tuberculosis has become apparent over the past 2 decades, and in particular, multidrug-resistant tuberculosis (MDR-TB; resistant to isoniazid and rifampin) and extensively drug-resistant tuberculosis (XDR-TB; resistant to isoniazid and rifampin, plus any fluoroquinolone and at least 1 o…”
BackgroundSelwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574 · cited 1×
“For example, individuals who have a prior latent infection with Mtb (not treated) and then acquire HIV infection will develop TB disease at an approximate rate of 5%–10% per year (in the absence of effective HIV treatment) [18, 19].”
Background(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Self-citationMolecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Research works printed but not linked: 8
- World Health Organization, 2015, Global tuberculosis report 2015
- T-SPOT.TB: an aid in the diagosis of tuberculosis infection; package insert for in vitro diagnositic use
- Perez, 2005, Impact of screening for latent TB before initiating anti-TNF therapy in North America and Europe, Ann Rheum Dis, 64, 265
- US Food and Drug Administration, 2008, Medical devices: T-SPOT-TB—P070006
- Forbes, 2008, Laboratory detection and identification of mycobacteria; approved guideline
- Francis J. Curry National Tuberculosis Center and California Department of Public Health, 2008, Drug-resistant tuberculosis: a survival guide for clinicians
- World Health Organization, 2008, Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB)
- Ena, 1990, The usefulness and limitations of adenosine deaminase in the diagnosis of tubercular pleurisy. A meta-analytical study [in Spanish], Med Clin (Barc), 95, 333
Cited by
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
“A cytokine release assay analogous to the tuberculosis IFNg release assay is a possibility (Lewinsohn et al., 2017; Murugesan et al., 2020; Petrone et al., 2020), as are plasmaCXCL10 (Rydyznski Moderbacher et al.”
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy381 · Cited by 641
“The figures for free IFN-λ were ≥89% and ≥97% for sensitivity and specificity, respectively [121].”
BackgroundMethodThe global prevalence of latent tuberculosis: A systematic review and meta-analysis
Cohen, A., Mathiasen, V. D., Schön, T., & Wejse, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00655-2019 · Cited by 547
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Nahid, P., Mase, S. R., Migliori, G. B., Sotgiu, G., Bothamley, G. H., Brozek, J. L., Cattamanchi, A., Cegielski, J. P., Chen, L., Daley, C. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1874st · Cited by 462
“The WHO-recommended standardized shorter-course 9-to 11-month regimen for MDR-TB was estimated by the guidelines committee to have minimal desirable effects (on treatment success, mortality, culture conversions) and small to moderate undesirable effects (adverse events, the use of drugs for which there is documented o…”
InfluentialSelf-citationMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy584 · Cited by 449
“The figures for free IFN-λ were ≥89% and ≥97% for sensitivity and specificity, respectively [121].”
BackgroundMethodGopalaswamy, R., Shanmugam, S., Mondal, R., & Subbian, S. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00667-6 · Cited by 350
“Culturing the bacteria in liquid or solid media is the “gold” reference standard for TB diagnosis, since this method performs better than AFB staining, and is cost-effective in resource-poor countries [68].”
BackgroundMethodInfluentialDiagnosis of severe respiratory infections in immunocompromised patients
Azoulay, E., Russell, L., Van de Louw, A., Metaxa, V., Bauer, P., Povoa, P., Montero, J. G., Loeches, I. M., Mehta, S., Puxty, K., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05906-5 · Cited by 346
Practical Guidance for Clinical Microbiology Laboratories: Mycobacteria
Forbes, B. A., Hall, G. S., Miller, M. B., Novak, S. M., Rowlinson, M.-C., Salfinger, M., Somoskövi, A., Warshauer, D. M., & Wilson, M. L. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00038-17 · Cited by 311
Self-citationAcharya, B., Acharya, A., Gautam, S., Ghimire, S. P., Mishra, G., Parajuli, N., & Sapkota, B. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05413-7 · Cited by 292
“Immunological methods such as TST, QFT and chest-X-ray are initial screening methods but providers should consider low predictive value of these tests in latent tuberculosis cases [76].”
MethodXpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
Horne, D. J., Kohli, M., Zifodya, J. S., Schiller, I., Dendukuri, N., Tollefson, D., Schumacher, S. G., Ochodo, E. A., Pai, M., & Steingart, K. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub4 · Cited by 267
“[DOI: 10.1503/cmaj.121286] Lewinsohn 2017 Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. OKicial American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults…”
BackgroundInfluentialSelf-citationTreatment of Community-Acquired Pneumonia in Immunocompromised Adults
Ramirez, J. A., Musher, D. M., Evans, S. E., Dela Cruz, C., Crothers, K. A., Hage, C. A., Aliberti, S., Anzueto, A., Arancibia, F., Arnold, F., et al. (2020) · Chest · doi:10.1016/j.chest.2020.05.598 · Cited by 234
“A list of common microbiologic studies with relevant clinical considerations is depicted in Table 6.(20-29)”
Nast, A., Smith, C., Spuls, P. I., Avila Valle, G., Bata‐Csörgö, Z., Boonen, H., De Jong, E., Garcia‐Doval, I., Gisondi, P., Kaur‐Knudsen, D., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16926 · Cited by 226
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Shaw, J. A., Diacon, A. H., & Koegelenberg, C. F. N. (2019) · Respirology · doi:10.1111/resp.13673 · Cited by 205
Kohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
White, A. C., Coyle, C. M., Rajshekhar, V., Singh, G., Hauser, W. A., Mohanty, A., Garcia, H. H., & Nash, T. E. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy157 · Cited by 212
“for all patients who will undergo prolonged treatment with corticosteroids.(30,31) The course of steroids used for many patients with SEL from NCC is often not a clear indication for prophylactic therapy for latent tuberculosis.”
Bjerrum, S., Schiller, I., Dendukuri, N., Kohli, M., Nathavitharana, R. R., Zwerling, A. A., Denkinger, C. M., Steingart, K. R., & Shah, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011420.pub3 · Cited by 186
“Around 5000 to 10,000 organisms per mL must be present in the specimen for tuberculosis bacteria to be visible by microscopy (Lewinsohn 2017).”
InfluentialZifodya, J. S., Kreniske, J. S., Schiller, I., Kohli, M., Dendukuri, N., Schumacher, S. G., Ochodo, E. A., Haraka, F., Zwerling, A. A., Pai, M., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub5 · Cited by 179
Self-citationBaddley, J. W., Cantini, F., Goletti, D., Gómez-Reino, J. J., Mylonakis, E., San-Juan, R., Fernández-Ruiz, M., & Torre-Cisneros, J. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.025 · Cited by 180
Subramanian, A. K., Theodoropoulos, N. M., & the Infectious Diseases Community of Practice of the American Society of Transplantation (2019) · Clinical Transplantation · doi:10.1111/ctr.13513 · Cited by 173
Gong, W., & Wu, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.745592 · Cited by 168
“tuberculosis antigens with no evidence of clinically manifest active TB” (Lewinsohn et al., 2017).”
BackgroundThe knowns and unknowns of latent Mycobacterium tuberculosis infection
Boom, W. H., Schaible, U. E., & Achkar, J. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136222 · Cited by 176
Qian, X., Nguyen, D. T., Lyu, J., Albers, A. E., Bi, X., & Graviss, E. A. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0106-1 · Cited by 162
Forty Years of Molecular Diagnostics for Infectious Diseases
Schmitz, J. E., Stratton, C. W., Persing, D. H., & Tang, Y. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.02446-21 · Cited by 193
“For instance, a respiratory or cerebrospinal fluid (CSF) specimen that is PCR negative forMycobacterium tuberculosismust still undergo several weeks of culture to evaluate for this organism with total certainty, which is slowly growing and can be present in specimens at extraordinarily low burdens (63).”
BackgroundLyme borreliosis: diagnosis and management
Kullberg, B. J., Vrijmoeth, H. D., van de Schoor, F. R., & Hovius, J. W. (2020) · BMJ · doi:10.1136/bmj.m1041 · Cited by 151
“Interferon gamma based cellular tests are well established for tuberculosis, but experimental for Lyme borreliosis 40 • In Lyme borreliosis, results are inconsistent because of small patient cohorts, no clear case definitions, no or poorly defined control groups, and lack of independent academic…”
Thomas, T. A. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.03.010 · Cited by 166
Shah, M., & Dorman, S. E. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp2108501 · Cited by 172
Peritoneal dialysis-related peritonitis: challenges and solutions
Salzer, W. L. (2018) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s123618 · Cited by 158
Roy‐Chowdhuri, S., Đačić, S., Ghofrani, M., Illei, P. B., Layfield, L. J., Lee, C. S., Michael, C. W., Miller, R. A., Mitchell, J. W., Nikolic, B., et al. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0119-cp · Cited by 158
“For the diagnosis of extrapulmonary tuberculosis, the guideline suggests that AFB smear microscopy, mycobacterial culture, and nucleic acid amplification tests be performed, although the sensitivity is lower for all methods than for pulmonary tuberculosis.(137) Note: In the section on diagnosis of extrapulmonary tuber…”
MethodLatent Tuberculosis: Two Centuries of Confusion
Behr, M. A., Kaufmann, E., Duffin, J., Edelstein, P. H., & Ramakrishnan, L. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202011-4239pp · Cited by 148
White, A. C., Coyle, C., Rajshekhar, V., Singh, G., Hauser, W. A., Mohanty, A., Garcia, H. H., & Nash, T. E. (2018) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.18-88751 · Cited by 125
“It is recommended for all patients who will undergo prolonged treatment with corticosteroids [30, 31].”
Anastasopoulou, A. N., Ziogas, D. C., Samarkos, M., Kirkwood, J. M., & Gogas, H. J. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0717-7 · Cited by 128
“…guidelines by WHO, USPSTF, ATS, CDC and IDSA support testing with IGRA over TST for diagnosis of LTBC in individuals with low-to-intermediate risk of progression to active disease, and either IGRA or TST or dual testing (if first one is negative) at highest risk of developing active MTB [51, 62].”
MethodSosa, L. E., Njie, G. J., Lobato, M. N., Morris, S. B., Buchta, W. G., Casey, M., Goswami, N. D., Gruden, M., Hurst, B. J., Khan, A. R., et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6819a3 · Cited by 125
“tuberculosis, and at low risk for progression on the basis of their risk assessment should have a second test (either an IGRA or a TST) as recommended in the 2017 TB diagnostic guidelines of the American Thoracic Society, Infectious Diseases Society of America, and CDC (16).”
InfluentialSelf-citationCentral Nervous System Infections
Giovane, R., & Lavender, P. D. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2018.05.007 · Cited by 130
Latent tuberculosis infection: Opportunities and challenges
Chee, C. B. E., Reves, R. R., Zhang, Y., & Belknap, R. (2018) · Respirology · doi:10.1111/resp.13346 · Cited by 113
Miele, K., Morris, S. B., & Tepper, N. K. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003890 · Cited by 106
Perez-Risco, D., Rodriguez-Temporal, D., Valledor-Sanchez, I., & Alcaide, F. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00659-18 · Cited by 103
“especially in nonrespiratory samples (2), and (ii) mycobacterial culture, which despite being considered the gold standard technique for TB diagnosis can take several weeks to provide a confirmation (3, 4).”
Brignardello‐Petersen, R., Carrasco‐Labra, A., & Guyatt, G. H. (2021) · JAMA · doi:10.1001/jama.2021.15319 · Cited by 107
Tuberculosis Infection in Children and Adolescents: Testing and Treatment
Nolt, D. L., & Starke, J. R. (2021) · PEDIATRICS · doi:10.1542/peds.2021-054663 · Cited by 99
“Low-level IGRA test conversions (negative to positive) and reversions (positive to negative) occur frequently among low-risk health care workers in serial testing programs and do not represent TBI.”
BackgroundMethodInfluentialAgrawal, R. V., Testi, I., Bodaghi, B., Barisani‐Asenbauer, T., McCluskey, P., Agarwal, A. K., Kempen, J. H., Gupta, A., Smith, J. R., de Smet, M. D., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.06.052 · Cited by 98
Screening for Latent Tuberculosis Infection in Adults
US Preventive Services Task Force, Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M. D., Chelmow, D. P., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., et al. (2023) · JAMA · doi:10.1001/jama.2023.4899 · Cited by 98
Peripheral Bacterial Septic Arthritis
Hassan, A. S., Rao, A. J., Manadan, A. M., & Block, J. A. (2017) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000588 · Cited by 92
“Unau tuberculosis, but may be confounded by colonizing organisms (bacteria or fungi) that are not the true causative organisms.(55,56) Synovial biopsies with culture are more sensitive and should be obtained whenever clinical suspicion is high.”
Coccidioidomycosis in Latin America
Laniado-Laborı́n, R., Arathoon, E., Canteros, C. E., Muñiz‐Salazar, R., & Rendón, A. (2018) · Medical Mycology · doi:10.1093/mmy/myy037 · Cited by 91
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
Migliori, G. B., Sotgiu, G., Rosales-Klintz, S., Centis, R., D’Ambrosio, L., Abubakar, I., Bothamley, G. H., Caminero, J. A., Cirillo, D. M., Dara, M., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02678-2017 · Cited by 87
Jaganath, D., Beaudry, J., & Salazar‐Austin, N. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.11.008 · Cited by 81
Tasillo, A., Salomon, J. A., Trikalinos, T. A., Horsburgh, C. R., Marks, S. M., & Linas, B. P. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3941 · Cited by 80
Potential Diagnostic Power of Blood Circular RNA Expression in Active Pulmonary Tuberculosis
Qian, Z., Liu, H., Li, M., Shi, J., Li, N., Zhang, Y., Zhang, X., Lv, J., Xie, X., Bai, Y., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.007 · Cited by 83
“The diagnosis of active pulmonary TB was based on established international guidelines (Lewinsohn et al., 2017).”
MethodTheel, E. S., Hilgart, H. R., Breen‐Lyles, M. K., McCoy, K., Flury, R., Breeher, L. E., Wilson, J., Sia, I. G., Whitaker, J. A., Clain, J. M., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00614-18 · Cited by 80
“Diagnosis of active TB infection or LTBI was based on criteria established by the recently updated TB diagnostic guidelines (14).”
Tuberculous meningitis: Challenges in diagnosis and management
Mechai, F., & Bouchaud, O. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.007 · Cited by 87
Pillay, S., Steingart, K. R., Davies, G., Chaplin, M., de Vos, M., Schumacher, S. G., Warren, R. M., & Theron, G. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014841.pub2 · Cited by 94
Diagnosis of tuberculous pleural effusions: A review
Cascio, C. M. L., Kaul, V., Dhooria, S., Agrawal, A., & Chaddha, U. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106607 · Cited by 89
Bronchoscopic techniques in the management of patients with tuberculosis
Mondoni, M., Repossi, A. C., Carlucci, P., Centanni, S., & Sotgiu, G. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.08.008 · Cited by 78
“Bronchoscopy with bronchial washing (BW), bronchoalveolar lavage (BAL), and biopsy can play a key role in the collection of suitable samples for TB diagnosis (Lewinsohn et al., 2017).”
BackgroundMethodCole, B., Nilsen, D. M., Will, L., Etkind, S. C., Burgos, M. V., & Chorba, T. L. (2020) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6907a1 · Cited by 76
“MDR TB should be considered in patients with of a history of previous TB treatment or who are from a country with high MDR TB rates (37).”
InfluentialAntibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis
Lu, L. L., Das, J., Grace, P. S., Fortune, S. M., Restrepo, B. I., & Alter, G. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz643 · Cited by 78
“A blood-based diagnostic test could transform care, particularly in children or extrapulmonary disease where sputum production may be difficult or less helpful [2].”
Tuberculosis of the gastrointestinal tract and associated viscera
Malikowski, T. M., Mahmood, M., Smyrk, T. C., Raffals, L. H., & Nehra, V. (2018) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2018.04.003 · Cited by 75
“Rapid molecular drug susceptibility testing is recommended for patients who have been previously treated for tuberculosis, have been in contact with patients with known MDR TB, those who were born in or spent more than one year in a country with a moderate TB incidence (≥20 cases per 100 000 people or a MDR TB prevale…”
The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives
Maiolini, M., Gause, S., Taylor, J., Steakin, T., Shipp, G. M., Lamichhane, P., Deshmukh, B., Shinde, V. M., Bishayee, A., & Deshmukh, R. R. (2020) · Molecules · doi:10.3390/molecules25133011 · Cited by 78
“The TST has been the standard method of diagnosing latent TB infections [17].”
Pancreatic tuberculosis: A systematic review of symptoms, diagnosis and treatment
Panić, N., Maetzel, H., Bulajic, M. M., Radovanovic, M., & Löhr, M. J. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620902353 · Cited by 78
Managing latent tuberculosis infection and tuberculosis in children
Carvalho, I., Goletti, D., Manga, S., Silva, D. R., Manissero, D., & Migliori, G. B. (2018) · Pulmonology · doi:10.1016/j.rppnen.2017.10.007 · Cited by 88
“Investigation of contacts of persons with TB, with special efforts with children aged <5 years and immunocompromised people and treating all contacts with latent TB infection (LTBI), becomes essential to reduce TB incidence in childhood.(7) The aim of this review is to describe the management of the child with TB and…”
BackgroundLi, L., Yang, L., Li, Z., Ye, Z., Zhao, W., & Gong, W. (2023) · Military Medical Research · doi:10.1186/s40779-023-00490-8 · Cited by 85
“MTB can persist in the human body for years without causing clinical symptoms, leading to a condition known as latent tuberculosis infection (LTBI) [4].”
BackgroundThe Global Fight Against Tuberculosis
Daley, C. L. (2018) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2018.09.010 · Cited by 69
Self-citationLipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?
Flores‐González, J., Cancino, J. C., & Chávez‐Galán, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.638047 · Cited by 74
Capsular glycan recognition provides antibody-mediated immunity against tuberculosis
Chen, T., Blanc, C., Liu, Y., Ishida, E., Singer, S., Xu, J., Joe, M., Jenny-Avital, E. R., Chan, J., Lowary, T. L., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci128459 · Cited by 65
“performed when the initial test (TST) was positive (36).”
InfluentialMunseri, P., Said, J., Amour, M. A., Magohe, A., Matee, M. I., Rees, C. A., MacKenzie, T. A., Tvaroha, S., Bailey‐Kellogg, C., Maro, I. I., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.09.055 · Cited by 66
The Use of Adjunctive Steroids in Central Nervous Infections
Gundamraj, S., & Hasbun, R. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.592017 · Cited by 70
Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment
Heidary, M., Shirani, M., Moradi, M., Goudarzi, M., Pouriran, R., Rezaeian, T., & Khoshnood, S. (2022) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2021.00021 · Cited by 76
“TST and IGRA tests have insufficient data to be suggested as the diagnostic methods in MTB-infected children, and they cannot distinguish active TB infection from LTBI in these patients [74].”
BackgroundMethodInterferon-γ Release Assay Performance for Tuberculosis in Childhood
Kay, A. W., Islam, S., Wendorf, K. A., Westenhouse, J. L., & Barry, P. M. (2018) · PEDIATRICS · doi:10.1542/peds.2017-3918 · Cited by 62
“Pulmonary only 343 (75) 65 (56) 98 (48) — CNS disease 17 (4) 9 (8) 19 (9) — Extrapulmonary only 79 (17) 29 (25) 72 (35) — >1 site, not CNS 17 (4) 14 (12) 16 (8) — Primary reason for TB evaluation — — — <.”
A borderline range for Quantiferon Gold In-Tube results
Jonsson, J., Westman, A., Bruchfeld, J., Sturegård, E., Gaines, H., & Schön, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187313 · Cited by 62
Shapiro, A. E., Ross, J. M., Yao, M., Schiller, I., Kohli, M., Dendukuri, N., Steingart, K. R., & Horne, D. J. D. L. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013694.pub2 · Cited by 81
“We have previously described selected alternative tests for detection of pulmonary tuberculosis and rifampicin resistance (Horne 2019; Lewinsohn 2017; Unitaid 2017).”
BackgroundMethodInfluentialLatent Tuberculosis: Two Centuries of Confusion.
Behr, M. A., Kaufmann, E., Duffin, J. M., Edelstein, P. H., & Ramakrishnan, L. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.71875 · Cited by 61
Caceres-Cardenas, G., Calderón, R., & Ugarte‐Gil, C. (2022) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361221095831 · Cited by 86
Ladumor, H., Al‐Mohannadi, S., Ameerudeen, F. S., Ladumor, S. B., & Fadl, S. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.02.012 · Cited by 68
Fehily, S. R., Al‐Ani, A., Abdelmalak, J., Rentsch, C. A., Zhang, E., Denholm, J. T., Johnson, D. F., Ng, S. C., Sharma, V., Rubin, D. T., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16952 · Cited by 64
Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline
Kucharzik, T. F., Dignass, A. U., Atreya, R. N., Bokemeyer, B., Esters, P., Herrlinger, K. R., Kannengießer, K., Kienle, P., Langhorst, J., Lügering, A., et al. (2020) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1296-3444 · Cited by 71
Diagnosis of tuberculosis: a consensus statement from the Brazilian Thoracic Association
Silva, D. R., Rabahi, M. F., Sant’Anna, C. C., Júnior, J. L. R. D. S., Capone6, D., Bombarda, S., de Miranda, S. S., da Rocha, J. L., Dalcolmo, M. P., Rick, M. F., et al. (2021) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20210054 · Cited by 153
“In addition, neither can predict disease progression nor differentiate latent from active tuberculosis.(58)”
Jain, D., Ghosh, S., Teixeira, L., & Mukhopadhyay, S. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.06.003 · Cited by 57
Holmberg, P. J., Temesgen, Z., & Banerjee, R. (2019) · Pediatrics in Review · doi:10.1542/pir.2018-0093 · Cited by 55
Cowger, T. L., Wortham, J. M., & Burton, D. C. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30134-3 · Cited by 60
Laycock, K. M., Enane, L. A., & Steenhoff, A. P. (2021) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed6030148 · Cited by 66
Engel, N., Ochodo, E., Karanja, P. W., Schmidt, B., Janssen, R., Steingart, K. R., & Oliver, S. R. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014877.pub2 · Cited by 60
“…W E E N P R O T O C O L A N D R E V I E W In the protocol, we wrote, "For the diagnosis of active tuberculosis disease, culture is regarded as the best available reference standard (Lewinsohn 2017), with liquid culture being more sensitive than solid culture (American Thoracic Society 2000).”
BackgroundInfluentialA Mycobacterium tuberculosis fingerprint in human breath allows tuberculosis detection
Mosquera-Restrepo, S. F., Zuberogoïtia, S., Gouxette, L., Layre, E., Gilleron, M., Stella, A., Rengel, D., Burlet‐Schiltz, O., Caro, A. C., García, L. F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35453-5 · Cited by 54
Dobler, C. C., Fox, G. J., Douglas, P. J., Viney, K. A., Khan, F. A., Temesgen, Z., & Marais, B. J. (2018) · European Respiratory Journal · doi:10.1183/13993003.00591-2018 · Cited by 59
“While culture is widely accepted as the reference standard for diagnosing active TB [52, 61, 62], its limitations include high cost and delayed diagnosis due to slow bacterial growth [63].”
BackgroundOleaga‐Quintas, C., de Oliveira-Júnior, E. B., Rosain, J., Rapaport, F., Deswarte, C., Guérin, A., Sajjath, S. M., Zhou, Y., Marot, S., Lozano, C., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00930-3 · Cited by 54
Feakins, R. M., Torres, J., Borralho, P., Burisch, J. M., Gonçalves, T. C., de Ridder, L., Driessen, A. L. C., Lobatón, T., Menchen, L. A., Mookhoek, A., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab141 · Cited by 64
Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?
Maphalle, L. N. F., Michniak‐Kohn, B. B., Ogunrombi, M. O., & Adeleke, O. A. (2022) · Children · doi:10.3390/children9081120 · Cited by 92
The interplay between tuberculosis and systemic lupus erythematosus
Balbi, G. G. M., Ribeiro, F. M., Marques, C. D. L., Signorelli, F., & Levy, R. A. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000493 · Cited by 53
Schiff, H. F., Jones, S., Achaiah, A., Pereira, A. M., Stait, G., & Green, B. (2019) · Scientific Reports · doi:10.1038/s41598-018-37350-8 · Cited by 54
Authors, & Collaborators: (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0824-0861 · Cited by 50
“Background Concerning the treatment of active tuberculosis, we recommend referring to guidelines issued by the RKI German Central Committee for the Control of Tuberculosis, or the current American guideline [550, 551].”
MethodTsang, C. A., Langer, A. J., Navin, T. R., & Armstrong, L. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6611a3 · Cited by 48
“If CDC and USPSTF recommendations are implemented (2,3), prevention activities, including screening for TB infection through the use of the tuberculin skin test or interferon-gamma release assays, might need to be expanded beyond the public health sector to include private providers and community health centers to bet…”
MethodResultEstévez, O., Anibarro, L., Garet, E., Martínez-Pérez, A., Peña, A., Barcia, L., Peleteiro, M., & González‐Fernández, Á. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.064 · Cited by 56
Nast, A., Altenburg, A., Augustin, M., Boehncke, W., Härle, P., Klaus, J., Koza, J., Mrowietz, U., Ockenfels, H. M., Philipp, S., et al. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14507 · Cited by 50
Wang, J., Zhu, X., Xiong, X., Ge, P., Liu, H., Ren, N., Khan, F. A., Zhou, X., Zhang, L., Yuan, X., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0066-5 · Cited by 46
Authors, & Collaborators: (2018) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0651-8174 · Cited by 62
“Hintergrund Bezüglich der Behandlung einer aktiven Tuberkulose wird auf die Empfehlungen des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose des Robert Koch-Instituts verwiesen sowie auf eine aktuelle amerikanische Leitlinie [550, 551].”
BackgroundInterferon-γ Release Assays in Children <15 Years of Age
Ahmed, A. I., Feng, P.-J. I., Gaensbauer, J. T., Reves, R. R., Khurana, R., Salcedo, K. L., Punnoose, R., & Katz, D. J. (2019) · PEDIATRICS · doi:10.1542/peds.2019-1930 · Cited by 45
“Current US guidelines recommend IGRAs for children $5 years old, for whom the risk of progression to disease is the same as for adults.(11) TST is recommended for younger children, in whom the risk of progression to tuberculosis is 4 to 5 times higher, primarily on the basis of studies that suggest diminished IGRA sen…”
BackgroundRimal, R., Shrestha, D., Pyakurel, S., Poudel, R., Shrestha, P., Rai, K. R., Ghimire, G. R., Rai, G., & Rai, S. K. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07287-5 · Cited by 45
“Also, culture requires a biosafety level 3 laboratory [20, 21].”
Undernutrition as a risk factor for tuberculosis disease
Franco, J. V. A., Bongaerts, B. W. C., Metzendorf, M., Risso, A., Guo, Y., Silva, L. P., Boeckmann, M., Schlesinger, S., Damen, J. A., Richter, B., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015890.pub2 · Cited by 97
Sali, M., Buonsenso, D., D’Alfonso, P., Maio, F. D., Ceccarelli, M., Battah, B., Palucci, I., Chiacchio, T., Goletti, D., Sanguinetti, M., et al. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.09.011 · Cited by 41
Luo, W., Lin, Y., Li, Z., Wang, W., & Shi, Y. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01192-w · Cited by 42
A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies
Schoenberg, N. C., Barker, A. F., Bernardo, J., Deterding, R. R., Ellner, J. J., HESS, D. R., MacIntyre, N. R., Martínez, F. J., & Wilson, K. C. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-0926oc · Cited by 44
“Guidelines on the Diagnosis of Tuberculosis (12):”
The re-emerging association between tuberculosis and diabetes: Lessons from past centuries
Cadena, J., Rathinavelu, S., López-Alvarenga, J. C., & Restrepo, B. I. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.04.015 · Cited by 44
“Today we use the tuberculin skin test (developed in 1934) and interferon gamma release assays to help diagnose infection in non-symptomatic patients [22].”
Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis
Schumacher, S. G., Wells, W. A., Nicol, M. P., Steingart, K. R., Theron, G., Dorman, S. E., Pai, M., Churchyard, G., Scott, L. E., Stevens, W. S., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz258 · Cited by 40
“For patients without HIV, cough ≥ 2 weeks is used to identify patients with suspected TB [19, 20], whereas less stringent criteria (cough of any duration, fever, night sweats, or weight loss) is used for PWH and other high-risk groups [21].”
Self-citation
Metadata
- Authors
- Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., O’Brien, R. J., Pai, M., Richeldi, L., Salfinger, M., Shinnick, T. M., Sterling, T. R., Warshauer, D. M., & Woods, G. L.
- Affiliations
- Oregon Health & Science University (US)
- Emory University School of Medicine and
- Centers for Disease Control and Prevention (US)
- Denver Public Health (US)
- National Jewish Health (US)
- California Department of Public Health (US)
- St. James's Hospital (IE)
- Francis J. Curry International TB Center, San Francisco, California;
- FIND (CH)
- McGill University (CA)
- University of Southampton (GB)
- Vanderbilt University (US)
- Wisconsin State Laboratory of Hygiene, Madison, and
- University of Arkansas for Medical Sciences (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-08
- Volume
- 64
- Issue
- 2
- Pages
- e1-e33
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5504475
- OpenAlex
- W2559832962
- Cited by
- 992
- References
- 246
- Citations by year
- 2026: 65 · 2025: 81 · 2024: 91 · 2023: 101 · 2022: 115 · 2021: 142 · 2020: 133 · 2019: 110 · 2018: 96 · 2017: 55 · 2016: 1
- FWCI
- 80.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, latent tuberculosis infection, pulmonary tuberculosis, extrapulmonary tuberculosis, Mycobacterium tuberculosis, diagnostic testing, children, adults
- MeSH terms
- Adult, Age Factors, Child, Humans, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Pulmonary, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.